A comparison of four epidemic waves of COVID-19 in Malawi; an observational cohort study
- PMID: 36750921
- PMCID: PMC9902830
- DOI: 10.1186/s12879-022-07941-y
A comparison of four epidemic waves of COVID-19 in Malawi; an observational cohort study
Abstract
Background: Compared to the abundance of clinical and genomic information available on patients hospitalised with COVID-19 disease from high-income countries, there is a paucity of data from low-income countries. Our aim was to explore the relationship between viral lineage and patient outcome.
Methods: We enrolled a prospective observational cohort of adult patients hospitalised with PCR-confirmed COVID-19 disease between July 2020 and March 2022 from Blantyre, Malawi, covering four waves of SARS-CoV-2 infections. Clinical and diagnostic data were collected using an adapted ISARIC clinical characterization protocol for COVID-19. SARS-CoV-2 isolates were sequenced using the MinION™ in Blantyre.
Results: We enrolled 314 patients, good quality sequencing data was available for 55 patients. The sequencing data showed that 8 of 11 participants recruited in wave one had B.1 infections, 6/6 in wave two had Beta, 25/26 in wave three had Delta and 11/12 in wave four had Omicron. Patients infected during the Delta and Omicron waves reported fewer underlying chronic conditions and a shorter time to presentation. Significantly fewer patients required oxygen (22.7% [17/75] vs. 58.6% [140/239], p < 0.001) and steroids (38.7% [29/75] vs. 70.3% [167/239], p < 0.001) in the Omicron wave compared with the other waves. Multivariable logistic-regression demonstrated a trend toward increased mortality in the Delta wave (OR 4.99 [95% CI 1.0-25.0 p = 0.05) compared to the first wave of infection.
Conclusions: Our data show that each wave of patients hospitalised with SARS-CoV-2 was infected with a distinct viral variant. The clinical data suggests that patients with severe COVID-19 disease were more likely to die during the Delta wave.
Keywords: Africa; COVID; Delta; ISARIC; LMIC; Malawi; Mortality; SARS-CoV-2.
© 2023. The Author(s).
Conflict of interest statement
We have no conflicts of interest to declare.
Figures
Update of
-
A comparison of four epidemic waves of COVID-19 in Malawi; an observational cohort study.medRxiv [Preprint]. 2022 Jul 11:2022.02.17.22269742. doi: 10.1101/2022.02.17.22269742. medRxiv. 2022. Update in: BMC Infect Dis. 2023 Feb 7;23(1):79. doi: 10.1186/s12879-022-07941-y. PMID: 35860218 Free PMC article. Updated. Preprint.
References
-
- Brito AF, Semenova E, Dudas G, et al. Global disparities in SARS-CoV-2 genomic surveillance. medRxiv 2021; :2021.08.21.21262393.
-
- Novel 2019 coronavirus genome—SARS-CoV-2 coronavirus. 2020. Available at: https://virological.org/t/novel-2019-coronavirus-genome/319. Accessed 28 October 2021.
-
- CDC. CDC’s Diagnostic Test for COVID-19 Only and Supplies. 2020. Available at: https://www.cdc.gov/coronavirus/2019-ncov/lab/virus-requests.html. Accessed 28 October 2021.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
